Even so, the results may trigger an increase in the use of the drug, which is now primarily used to treat angina, doctors said.
Diltiazem is a calcium entry blocker, the newest class of drugs to be introduced in the fight against heart disease.
Dr. John Schroeder, a cardiologist and professor at Stanford University, said he was surprised that the drug increased the chance of heart attack in any group and that overall results were not higher.
The results suggest the drug may be quite effective in decreasing the likelihood of a second heart attack in the majority of patients, Moss said.
